Filing Flows › Dentsply Sirona (XRAY) › Q2 2026 › vs Q1 2026
Dentsply Sirona (XRAY) Q2 2026 vs Q1 2026 (quarter over quarter)
Dentsply Sirona's revenue rose $18.0M (+2%) from $880M in Q1 2026 to $898M in Q2 2026. Gross margin 54.9% against 48.5% (+6.4 pts).
Dentsply Sirona, Q2 2026: revenue $898M (-4% year over year), operating margin 9.1%, net earnings $37.0M, operating cash flow $99.0M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 54.9% | 48.5% | +6.4 pts |
| Operating margin | 9.1% | -4.0% | +13.1 pts |
| Net margin | 4.1% | -1.1% | +5.3 pts |
| Free cash flow margin | 6.1% | -1.4% | +7.5 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $898M | $880M | $18.0M | +2% |
| Gross profit | $493M | $427M | $66.0M | +15% |
| Cost of revenue | $405M | $453M | −$48.0M | -11% |
| Operating profit | $82.0M | −$35.0M | $117M | — |
| Operating expenses | $411M | $462M | −$51.0M | -11% |
| Pre-tax earnings | $72.0M | −$42.0M | $114M | — |
| Other expense, net | $10.0M | $7.0M | $3.0M | +43% |
| Research & development | $45.0M | $44.0M | $1.0M | +2% |
| SG&A | $364M | $351M | $13.0M | +4% |
| Other operating costs | $2.0M | $67.0M | −$65.0M | -97% |
| Loss borne by minority interests | $1.0M | $0 | $1.0M | — |
| Net earnings | $37.0M | −$10.0M | $47.0M | — |
| Income tax | $36.0M | −$32.0M | $68.0M | — |
| Depreciation & amortization | $85.0M | $79.0M | $6.0M | +8% |
| Share-based compensation | $9.0M | $8.0M | $1.0M | +12% |
| Working capital & other | $32.0M | $37.0M | −$5.0M | -14% |
| Operating cash flow | $99.0M | $40.0M | $59.0M | +148% |
| Free cash flow (OCF − capex) | $55.0M | −$12.0M | $67.0M | — |
| Capital expenditures | $44.0M | $52.0M | −$8.0M | -15% |
Questions
How much did Dentsply Sirona's revenue grow quarter over quarter in Q2 2026?
Dentsply Sirona's revenue rose $18.0M (+2%) from $880M in Q1 2026 to $898M in Q2 2026. Gross margin 54.9% against 48.5% (+6.4 pts).